| Stemline Therapeutics Switzerland GmbH - Orserdu 345 mg, Filmtabletten | | 69417 | | 02 | | Orserdu 345 mg | | Filmtabletten | | L02BA04 | | Elacestrant | | 04.06.2024 | | |
| | Composition | | Filmtablette: elacestrantum 345 mg ut elacestranti dihydrochloridum, cellulosum microcristallinum, crospovidonum, magnesii stearas, silica colloidalis anhydrica, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 133, pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. | informations additionels |
|---|
| Elacestrantum | 345 mg | Filmtablette |
| | BAG: Principe actif | Concentr. |
|---|
| Elacestrantum | 345 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Cellulosum Microcristallinum | | | | Crospovidonum | | | | E 133 | | color. | | E 171 | | color. | | Macrogol | 3350 | | | Magnesii Stearas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | 28 | 7115.52 | 7608.30 | B | LS | Non |
|
|
